We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.2B
1-Year Est. Return 38.92%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+308.35%
AUM
$6.7B
AUM Growth
-$277M
Cap. Flow
-$747M
Cap. Flow %
-11.15%
Top 10 Hldgs %
35.66%
Holding
110
New
3
Increased
15
Reduced
63
Closed
9

Top Buys

Rank Stock Value
1
ADNT icon
Adient
ADNT
+$65.3M
2
SHEL icon
Shell
SHEL
+$56.7M
3
MGA icon
Magna International
MGA
+$28.3M
4
SWKS icon
Skyworks Solutions
SWKS
+$18.3M
5
MAC icon
Macerich
MAC
+$15M

Sector Composition

Rank Sector Weight
1 Financials 29.09%
2 Communication Services 16.29%
3 Energy 13.06%
4 Materials 12.61%
5 Healthcare 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PROF
76
Profound Medical
PROF
$269M
$11.7M 0.17%
1,299,125
+476,875
+58% +$4.59M
FTS icon
77
Fortis
FTS
$28.7B
$8.58M 0.13%
173,375
+600
+0.3% +$28.1K
FLR icon
78
Fluor
FLR
$7.96B
$8.49M 0.13%
295,920
-4,900
-2% -$118K
PDS
79
Precision Drilling
PDS
$974M
$8.26M 0.12%
111,340
-31,081
-22% -$1.65M
GT icon
80
Goodyear
GT
$1.85B
$5.53M 0.08%
387,108
-20,450
-5% -$363K
YTRA icon
81
Yatra Online
YTRA
$52.6M
$4.23M 0.06%
2,138,020
SCHW
82
Charles Schwab
SCHW
$187B
$1.84M 0.03%
21,846
VT icon
83
Vanguard Total World Stock ETF
VT
$81.3B
$1.47M 0.02%
14,500
ING icon
84
ING
ING
$102B
$1.02M 0.02%
98,312
-252
-0.3% -$3.28K
OM icon
85
Outset Medical
OM
$90.8M
$1.02M 0.02%
1,500
MET icon
86
MetLife
MET
$62.1B
$921K 0.01%
13,099
MYOV
87
DELISTED
Myovant Sciences Ltd.
MYOV
$842K 0.01%
63,204
SPRO icon
88
Spero Therapeutics
SPRO
$73M
$641K 0.01%
73,659
ENB icon
89
Enbridge
ENB
$112B
$491K 0.01%
10,650
NUE icon
90
Nucor
NUE
$62.1B
$431K 0.01%
2,900
REPL icon
91
Replimune Group
REPL
$1.01B
$387K 0.01%
22,800
DUK icon
92
Duke Energy
DUK
$97.3B
$346K 0.01%
3,100
BABA icon
93
Alibaba
BABA
$308B
$337K 0.01%
3,100
HRTX icon
94
Heron Therapeutics
HRTX
$92.9M
$327K ﹤0.01%
57,200
KMB icon
95
Kimberly-Clark
KMB
$36.5B
$249K ﹤0.01%
2,025
IMV
96
DELISTED
IMV Inc. Common Shares
IMV
$245K ﹤0.01%
17,000
PBA icon
97
Pembina Pipeline
PBA
$27.6B
$204K ﹤0.01%
+5,425
New +$183K
ATRA icon
98
Atara Biotherapeutics
ATRA
$76.1M
$146K ﹤0.01%
628
MDNA
99
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$128K ﹤0.01%
100,000
ONCR
100
DELISTED
Oncorus, Inc.
ONCR
$105K ﹤0.01%
59,150
+34,400
+139% +$96.4K

Similar funds

Letko, Brosseau & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Letko, Brosseau & Associates held 110 positions worth $6.7B, down 4% from $6.98B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Letko, Brosseau & Associates withdrew a net $747M in Q1 2022, closing 9 positions and reducing 63 holdings. Its most notable exit was PRETIUM RESOURCES INC., an estimated $101M position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 29% a quarter earlier, followed by Communication Services and Energy.

Against the trend, Letko, Brosseau & Associates opened a new position in Adient worth $62M.

  • Letko, Brosseau & Associates's largest Q1 2022 buy was Adient: 1,519,625 shares worth $62M.
  • Letko, Brosseau & Associates added most to Magna International in Q1 2022, an estimated $28.3M increase.
  • Letko, Brosseau & Associates's biggest Q1 2022 reduction was Cenovus Energy, cutting an estimated $87.9M.
  • Letko, Brosseau & Associates fully exited PRETIUM RESOURCES INC. in Q1 2022, selling an estimated $101M.
  • Letko, Brosseau & Associates's ten largest holdings make up 36% of its $6.7B portfolio in Q1 2022.
  • Letko, Brosseau & Associates opened 3 new positions and closed 9 in Q1 2022.
  • Letko, Brosseau & Associates's portfolio value fell 4% quarter-over-quarter to $6.7B.

Based on Letko, Brosseau & Associates's 13F filing for Q1 2022, filed 11 May 2022.